Vivani Medical, Inc.
VANI
$0.935
-$0.055-5.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -22.09% | -30.93% | -5.48% | -9.26% | 70.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.69% | -18.88% | -5.67% | 2.09% | 31.23% |
| Operating Income | 11.69% | 18.88% | 5.67% | -2.09% | -31.23% |
| Income Before Tax | 10.93% | 17.93% | 4.42% | 17.27% | -576.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.93% | 17.93% | 4.42% | 17.27% | -576.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.93% | 17.93% | 4.42% | 17.27% | -576.60% |
| EBIT | 11.69% | 18.88% | 5.67% | -2.09% | -31.23% |
| EBITDA | 12.39% | 19.38% | 5.62% | -2.32% | -32.38% |
| EPS Basic | 18.07% | 24.28% | 7.07% | 35.43% | -455.73% |
| Normalized Basic EPS | 18.11% | 24.28% | 7.07% | 15.75% | 7.13% |
| EPS Diluted | 18.07% | 24.28% | 7.07% | 35.43% | -455.73% |
| Normalized Diluted EPS | 18.11% | 24.28% | 7.07% | 15.75% | 5.87% |
| Average Basic Shares Outstanding | 8.67% | 8.32% | 2.85% | 28.11% | 33.90% |
| Average Diluted Shares Outstanding | 8.67% | 8.32% | 2.85% | 28.11% | 32.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
